Alzheimer's Disease clinical trials in Georgia
29 active Alzheimer's Disease trials with a site in Georgia. Describe your situation to see which ones you may be eligible for.
- A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
- A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Moving Yourself in Space and Time: MYSTIC
- A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- Alzheimer's Disease Neuroimaging Initiative 4
- Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- DECIDE: Dyads and Families
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.